Laurus Labs Limited
LAURUSLABS
주식 순위
#1741
Established in 2005 and headquartered in Hyderabad, India, Laurus Labs Limited,... Established in 2005 and headquartered in Hyderabad, India, Laurus Labs Limited, along with its subsidiaries, operates as a diversified global pharmaceutical company. It focuses on the research, manufacturing, and international distribution of a broad spectrum of medicines and active pharmaceutical ingredients (APIs). The company's API and advanced intermediate offerings cover key therapeutic domains such as anti-retroviral (ARV), antidiabetic, cardiovascular, proton pump inhibitors (PPIs), oncology, gastroenterology, and hepatitis C. Additionally, Laurus Labs develops and produces oral solid dosage forms targeting ARV, antidiabetic, cardiovascular, PPI, and central nervous system (CNS) conditions. Beyond its proprietary products, the firm extends its expertise through contract development and manufacturing services for other pharmaceutical enterprises. It also supplies specialized ingredients vital for nutraceutical, dietary supplement, and cosmeceutical applications. Furthermore, Laurus Labs is at the forefront of innovation, engineering novel enzymatic solutions for industrial biotechnology, and providing animal-origin-free recombinant proteins and enzymes for biopharmaceutical use, alongside offering a range of business support services within the pharmaceutical industry.
주가
$22.83
마지막 동기화: 2026-10-19
시가총액
$12.34B
변동 (1일)
0.51%
변동 (1년)
117.95%
국가
IN
거래 Laurus Labs Limited (LAURUSLABS)
카테고리
Healthcare
Laurus Labs Limited (LAURUSLABS)의 주식 분할 이력
Laurus Labs Limited 주식 (심볼: LAURUSLABS)은 총 1회의 주식 분할을 거쳤습니다.
가장 최근의 분할은 Sep 29, 2020에 발생했습니다.
Sep 29, 2020 이전에 매수한 LAURUSLABS 주식 1주는 현재 5주의 LAURUSLABS 주식에 해당합니다.
가장 최근의 분할은 Sep 29, 2020에 발생했습니다.
Sep 29, 2020 이전에 매수한 LAURUSLABS 주식 1주는 현재 5주의 LAURUSLABS 주식에 해당합니다.
주식 분할 목록
| 연도 | 주식 분할 | 배수 | 누적 배수 |
|---|---|---|---|
| 2020-09-29 | 5:1 | x5 | x5 |
유사 기업 또는 경쟁사의 주식 분할
| 회사 | 주식 분할 횟수 | 누적 배수 | 국가 |
|---|---|---|---|
| 0 | - |
DE
|
|
| 0 | - |
DE
|
|
| 0 | - |
JP
|
|
| 0 | - |
CH
|
|
| 5 | x119 |
IN
|
